The stock of Gossamer Bio Inc (NASDAQ:GOSS) last traded at $0.54, up 4.29% from the previous session.
GOSS stock price is now -22.76% away from the 50-day moving average and -37.48% away from the 200-day moving average. The market capitalization of the company currently stands at $122.70M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
On July 27, 2023, UBS Downgraded its previous ‘Buy’ rating to ‘Neutral’ on the stock reducing its target price from $8 to quote $1.25, while ‘Raymond James’ rates the stock as ‘Mkt Perform’
In other news, Hasnain Faheem, President & CEO sold 23,172 shares of the company’s stock on Mar 27 ’24. The stock was sold for $26,773 at an average price of $1.16. Upon completion of the transaction, the President & CEO now directly owns 120,293 shares in the company, valued at $64958.22. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 27 ’24, COO/CFO Giraudo Bryan sold 6,430 shares of the business’s stock. A total of $7,431 was realized by selling the stock at an average price of $1.16. This leaves the insider owning 92,737 shares of the company worth $50077.98. A total of 16.23% of the company’s stock is owned by insiders.
During the past 12 months, Gossamer Bio Inc has had a low of $0.45 and a high of $1.88. As of last week, the company has a debt-to-equity ratio of 7.82, a current ratio of 7.13, and a quick ratio of 7.13. The fifty day moving average price for GOSS is $0.69154 and a two-hundred day moving average price translates $0.86516 for the stock.
The latest earnings results from Gossamer Bio Inc (NASDAQ: GOSS) was released for 2024-03-31. The company reported revenue of $41.96 million for the quarter, compared to $47.94 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -12.48 percent.
